{"id":"hum0272","secondaryIds":[],"version":2,"url":"https://humandbs.dbcls.jp/research/hum0272/v2","datePublished":"2022-02-07","versions":[{"version":1,"datePublished":"2021-12-20"},{"version":2,"datePublished":"2022-02-07"},{"version":3,"datePublished":"2024-11-13"}],"title":{"ja":"メラノーマ等、皮膚腫瘍病変の免疫状態の解析","en":"Analysis of the immune status of melanoma and other skin tumors"},"summary":{"aims":{"ja":"メラノーマなどの皮膚腫瘍検体を用いた、がん細胞や免疫細胞などの遺伝子発現、体細胞遺伝子変異の解析","en":"Analysis of gene expression and somatic gene mutation in tumor cells and immune cells using skin tumor samples such as melanoma"},"methods":{"ja":"whole exome sequencing解析、RNA sequencing解析、scRNA sequencing解析、scTCR sequencing解析","en":"whole exome sequencing analysis, RNA sequencing analysis, scRNA sequencing analyses, scTCR sequencing analyses"},"targets":{"ja":"メラノーマ患者 4例","en":"melanoma patients: 4 cases"},"url":{"ja":[{"url":"https://www.ho.chiba-u.ac.jp/dept/dermatology/research/res/","text":"https://www.ho.chiba-u.ac.jp/dept/dermatology/research/res/"}],"en":null}},"listingSummary":{},"releaseNote":{"ja":"メラノーマ3症例の腫瘍組織から樹立した培養細胞、患者リンパ節、腫瘍浸潤リンパ球、末梢血リンパ球およびリンパ節の腫瘍浸潤リンパ球から抽出したDNA/RNAを用いたExome、scRNA-seq、scTCR-seq解析の結果を追加した。fastqおよびbamファイル形式で提供する。","en":"DNAs/RNAs extracted from cultured tumor cells from a melanoma patient, lymph nodes metastatic lesions of a melanoma case and TIL, PBL and LN-TIL of 3 melanoma cases were used for the whole exome sequencing, scRNA sequencing, and scTCR sequencing analyses. Fastq and bam files are provided."},"dataProviders":[{"name":{"ja":"猪爪 隆史","en":"Takashi Inozume"},"organization":{"name":{"ja":"千葉大学医学部 皮膚科","en":"Department of Dermatology, Chiba University"}}}],"researchProjects":[{"name":{"ja":"皮膚がんに対するより効果的な免疫療法の開発","en":"Development of more effective immunotherapy for skin cancer"},"url":{"ja":[{"url":"https://www.ho.chiba-u.ac.jp/dept/dermatology/research/res/","text":"https://www.ho.chiba-u.ac.jp/dept/dermatology/research/res/"}],"en":null}}],"grants":[{"title":{"ja":"抗PD-1抗体治療の効果を示す直接的バイオマーカーの検索","en":"Identification of essential biomarkers for efficacy of anti-PD-1 therapy"},"agency":{"ja":"科学研究費助成事業 基盤研究（C）","en":"KAKENHI Grant-in-Aid for Scientific Research (C)"},"grantIds":["19K08744"]}],"relatedPublications":[{"title":"TIGIT/CD155 axis mediates resistance to immunotherapy in patients with melanoma with the inflamed tumor microenvironment","doi":"https://doi.org/10.1136/jitc-2021-003134","datasets":["JGAD000391"]}],"datasets":["JGAD000391"],"controlledAccessUsers":[{"principalInvestigator":{"ja":"浜田 道昭","en":"Michiaki Hamada"},"affiliation":{"ja":"浜田研究室, 理工学術院, 早稲田大学","en":"Hamada Laboratory, Faculty of Science and Engineering, Waseda University"},"country":{"ja":"日本","en":"Japan"},"researchTitle":{"ja":"RNA標的創薬データベースの構築","en":"Construction of RNA-targeted Drug Discovery Database"},"periodStart":"2023-01-05","periodEnd":"2027-10-31","datasets":["JGAD000391","JGAD000717"]},{"principalInvestigator":{"ja":"山本 拓也","en":"Takuya Yamamoto"},"affiliation":{"ja":"プレシジョン免疫プロジェクト, 国立研究開発法人 医薬基盤・健康・栄養研究所","en":"Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition"},"country":{"ja":"日本","en":"Japan"},"researchTitle":{"ja":"新規がん抗原の同定に基づく消化器がんおよび悪性黒色腫（メラノーマ）に対するワクチン開発基盤研究\r\n","en":"Basic research for vaccine development against gastrointestinal cancer and malignant melanoma based on the identification of novel cancer antigens\r\n"},"periodStart":"2024-11-12","periodEnd":"2027-03-31","datasets":["JGAD000391"]}]}